Lixte Biotechnology H -CW25LIXTWPreferred / convertible
13F holders, Q1 2024 (March 31)4holders
$0.05avg. 13F price*
At the end of Q1 2024, 4 institutions reported holding Lixte Biotechnology H -CW25 (LIXTW) in their 13F filings. The largest holders were Warberg Asset Management LLC ($2K), Clear Street LLC ($1K) and UBS Group AG ($193).
- Company
- Lixte Biotechnology H -CW25
- CUSIP
- 539319111
- Latest filing quarter
- Q3 2025
History
Number of 13F holders
Total Exit/New Position Q1 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $5 |
| Exits | 0 | $0 |
Ownership 4 holders
| Warberg Asset Management LLC | — | No change | 40,875 | $2K |
| Clear Street LLC | — | Reduce -0.4% | 23,154 | $1K |
| UBS Group AG | — | Add +1734.8% | 3,853 | $193 |
| Bank of America Corp. | — | New | 100 | $5 |
"% of holder's portfolio" is LIXTW's weight in each manager's 13F, not the share of Lixte Biotechnology H -CW25 the manager owns.